phentermine has been researched along with Disease Models, Animal in 6 studies
Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To characterize the interactive effects of amylin with phentermine or sibutramine on food intake, body weight/composition and gene expression in diet-induced obese (DIO) rats." | 7.74 | Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats. ( Athanacio, J; Coffey, T; Kesty, NC; Lei, C; Mack, C; Parkes, DG; Roth, JD; Trevaskis, JL; Weyer, C; Wilson, J, 2008) |
| " Lorcaserin (Belviq(®)), phentermine/topiramate combination (Qsymia(®)), and bupropion/naltrexone combination have been demonstrated to be effective for the treatment of obesity, as an adjunct to a reduced-calorie diet and physical activity, although their absolute safety has yet to be established with more widespread use or longer use." | 3.79 | Therapies for obesity and medication-associated weight gain. ( Howland, RH, 2013) |
| "To characterize the interactive effects of amylin with phentermine or sibutramine on food intake, body weight/composition and gene expression in diet-induced obese (DIO) rats." | 3.74 | Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats. ( Athanacio, J; Coffey, T; Kesty, NC; Lei, C; Mack, C; Parkes, DG; Roth, JD; Trevaskis, JL; Weyer, C; Wilson, J, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howland, RH | 1 |
| Roth, JD | 1 |
| Trevaskis, JL | 1 |
| Wilson, J | 1 |
| Lei, C | 1 |
| Athanacio, J | 1 |
| Mack, C | 1 |
| Kesty, NC | 1 |
| Coffey, T | 1 |
| Weyer, C | 1 |
| Parkes, DG | 1 |
| Donnelly, KB | 1 |
| Reasor, MJ | 1 |
| Lüllmann-Rauch, R | 1 |
| Reil, GH | 1 |
| Blinzinger, K | 1 |
| Anzil, AP | 1 |
| Herrlinger, H | 1 |
1 review available for phentermine and Disease Models, Animal
| Article | Year |
|---|---|
Cardiac valvular pathology: comparative pathology and animal models of acquired cardiac valvular diseases.
Topics: Animals; Appetite Depressants; Disease Models, Animal; Dogs; Fenfluramine; Heart Valve Diseases; Hea | 2008 |
5 other studies available for phentermine and Disease Models, Animal
| Article | Year |
|---|---|
Therapies for obesity and medication-associated weight gain.
Topics: Animals; Appetite Depressants; Bariatric Surgery; Benzazepines; Bupropion; Chronic Disease; Combined | 2013 |
Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
Topics: Amyloid; Animals; Anti-Obesity Agents; Body Composition; Body Weight; Cyclobutanes; Diet; Disease Mo | 2008 |
Phospholipidosis in the alveolar macrophage induced by cationic amphiphilic drugs.
Topics: Animals; Chlorphentermine; Disease Models, Animal; Lipid Metabolism, Inborn Errors; Macrophages; Mal | 1984 |
Chlorphentermine-induced lipidosislike ultrastructural alterations in testicular Leydig and Sertoli cells.
Topics: Animals; Chlorphentermine; Crystallography; Disease Models, Animal; Inclusion Bodies; Leydig Cells; | 1975 |
[Intravital tellurium labeling of lysosomal storage organoids in exogenous lipoidosis].
Topics: Cerebral Cortex; Disease Models, Animal; Inclusion Bodies; Lipidoses; Lysosomes; Microscopy, Electro | 1974 |